Code | 1846E | ||||||||||
MA number | 44/0190/23-S | ||||||||||
Product Form: | sol inj 1x2 ml/0,88 mg (liek.inj.skl.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 08.09.2023 |
Validity: | 08.09.2028 |
SPC: | SPC_Eribulin ADVZ 0,44 mg_ml injekčný roztok_08_2023.pdf |
PIL: | PIL_Eribulin ADVZ 0,44 mg_ml injekčný roztok_08_2023.pdf |
Safety feature | Yes |
Data update: | 13.09.2023 |